Cervical human papillomavirus testing to triage borderline abnormal pap tests in HIV-coinfected women.
作者信息
DʼSouza Gypsyamber, Burk Robert D, Palefsky Joel M, Massad L S, Strickler Howard D
机构信息
aJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland bAlbert Einstein College of Medicine, Bronx, New York cUniversity of California, San Francisco, California dWashington University School of Medicine, St Louis, Missouri, USA. *The HPV Working Group includes the named authors, as well as the following who were each involved in the design of the study, interpretation of the data and approval of the manuscript: Xianhong Xie, PhD, Xiaonan Xue, PhD, Teresa Darragh, MD, Isam-Eldin Eltoum, MD, Cecile Anne Delille, MD, Lisa Rahangdale, MD, Maria Alcaide, MD, Alexandra M. Levine, MD, Christine Colie, MD, and Rodney Wright, MD, and Howard Minkoff, MD.
出版信息
AIDS. 2014 Jul 17;28(11):1696-8. doi: 10.1097/QAD.0000000000000285.
Abstract
摘要
相似文献
1
Cervical human papillomavirus testing to triage borderline abnormal pap tests in HIV-coinfected women.
AIDS. 2014 Jul 17;28(11):1696-8. doi: 10.1097/QAD.0000000000000285.
2
Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
Compr Ther. 2001 Fall;27(3):202-8. doi: 10.1007/s12019-001-0015-3.
3
Human papillomavirus DNA and Pap tests: the need for cotesting in opportunistic setting during the transition time.
J Low Genit Tract Dis. 2013 Jul;17(3):362-5. doi: 10.1097/LGT.0b013e31826f24c0.
4
[Methods of HPV detection in exfoliated cells and tissue specimens approved by the United States Food and Drug Administration].
Zhonghua Bing Li Xue Za Zhi. 2012 Dec;41(12):855-7. doi: 10.3760/cma.j.issn.0529-5807.2012.12.018.
5
Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Cytopathology. 2019 Mar;30(2):150-156. doi: 10.1111/cyt.12652. Epub 2018 Dec 6.
6
Testing for human papillomavirus in women with abnormal pap smear results.
JAMA. 2002 Sep 18;288(11):1350; author reply 1351-2.
7
Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from HIV-1-infected African women.
J Clin Microbiol. 2013 Dec;51(12):4240-2. doi: 10.1128/JCM.02144-13. Epub 2013 Oct 9.
8
Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
Int J Gynecol Cancer. 2006 Mar-Apr;16(2):599-603. doi: 10.1111/j.1525-1438.2006.00377.x.
9
Introduction of human papillomavirus DNA screening in the world: 15 years of experience.
Vaccine. 2012 Nov 20;30 Suppl 5:F117-22. doi: 10.1016/j.vaccine.2012.05.071.
10
Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
J Med Virol. 2013 Mar;85(3):472-82. doi: 10.1002/jmv.23487. Epub 2012 Dec 26.
引用本文的文献
1
Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus.
Clin Infect Dis. 2021 May 4;72(9):1529-1537. doi: 10.1093/cid/ciaa1317.
2
Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.
AIDS. 2017 Apr 24;31(7):1035-1044. doi: 10.1097/QAD.0000000000001450.
3
Human Papillomavirus at Multiple Sites Associated with Anal Squamous Intraepithelial Lesions in HIV-Seropositive Individuals.
Ann Clin Cytol Pathol. 2016;2(4). Epub 2016 Jul 12.
4
Screening for Cancer in Persons Living with HIV Infection.
Trends Cancer. 2016 Aug;2(8):416-428. doi: 10.1016/j.trecan.2016.06.007.
5
Screening for Human Papillomavirus-Associated Cervical Disease in HIV-Infected Women.
Top Antivir Med. 2015 Oct-Nov;23(4):142-5.
本文引用的文献
1
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Obstet Gynecol. 2013 Apr;121(4):829-846. doi: 10.1097/AOG.0b013e3182883a34.
2
Marginal and mixed-effects models in the analysis of human papillomavirus natural history data.
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):159-69. doi: 10.1158/1055-9965.EPI-09-0546.
3
High-risk human papillomavirus and cervical intraepithelial neoplasia at time of atypical squamous cells of undetermined significance cytologic results in a population with human immunodeficiency virus.
J Low Genit Tract Dis. 2004 Oct;8(4):298-303. doi: 10.1097/00128360-200410000-00007.
4
Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
J Natl Cancer Inst. 2005 Apr 20;97(8):577-86. doi: 10.1093/jnci/dji073.
5
HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance.
J Womens Health (Larchmt). 2004 Mar;13(2):147-53. doi: 10.1089/154099904322966128.
6
Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women.
J Infect Dis. 1996 Oct;174(4):679-89. doi: 10.1093/infdis/174.4.679.
Zotero 插件